EcoDrugPlus

Adrenoceptor Alpha 2b

Ensembl ID : ENSCHYG00000011487
Gene Symbol: ADRA2B
1 Cross references
222 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSCHYG00000012704
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSCHYG00000003348
Gene Symbol: ADRB2
1 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSCHYG00000022213
Gene Symbol: ADRB3
1 Cross references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSCHYG00000002222
Gene Symbol: AGER
1 Cross references
170 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSCHYG00000010599
Gene Symbol: GAA
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSCHYG00000024344
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSCHYG00000015004
Gene Symbol: APCS
1 Cross references
402 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCHYG00000017698
Gene Symbol: APP
1 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSCHYG00000012242
Gene Symbol: AR
1 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSCHYG00000009236
Gene Symbol: ACE
1 Cross references
92 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCHYG00000011650
Gene Symbol: AGTR1
1 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).